INTRODUCTION
Diverticular disease (DD) is the fifth most important gastrointestinal disease in terms of healthcare costs in Western countries, with the highest rates in the United States and Europe. All age groups can be affected but prevalence increases with age, and cases in younger individuals are more likely to be complicated [1] [2] [3] . Diverticular diseases is a term used to include diverticulosis and diverticulitis and it may denote a clinically significant and symptomatic condition or asymptomatic diverticulosis.
In the vast majority of individuals, colonic diverticula remain symptomless (diverticulosis), while approximately 20% of them develop symptoms, including recurrent abdominal pain or discomfort, bloating, changing in bowel habits (symptomatic diverticular disease). Only about 4% of patients develop acute diverticulitis, contradicting the common belief that diverticulosis has a high rate of progression [4, 5] .
A significant proportion of patients with DD complain of symptoms resembling or overlapping those of irritable bowel syndrome (IBS), making a clear differentiation between the two conditions challenging [6] [7] [8] . It has been reported that, beyond abdominal symptoms, symptomatic DD is associated with a reduced quality of life, in particular vitality and emotional J Gastrointestin Liver Dis, March 2016 Vol. 25 No 1: 79-86 health [9, 10] , suggesting that DD may be experienced as a chronic illness marked by ongoing abdominal symptoms and psychosocial distress [11, 12] . A recent report showed that patients with acute diverticulitis may be at risk for subsequent development of IBS, a condition for which the term postdiverticulitis IBS has been proposed [11] , analogously to postinfectious IBS proposed some years ago [13] . Both conditions, DD and IBS, presumably share some pathophysiological factors leading to symptom generation as low-grade inflammation, visceral hypersensitivity, abnormal colonic motility, and altered intestinal microbiota [14] [15] [16] [17] [18] [19] . Changes in peri-diverticular bacterial flora has been suggested as a potential key step in the pathogenesis of diverticular inflammation and abdominal symptoms in DD [15] , thus making probiotics an appealing therapy for this condition [20, 21] .
Probiotics may modify the gut microbial balance leading to health benefits due to their anti-inflammatory effects and capability to enhance anti-infection defences by maintaining an adequate bacterial colonization in the gastrointestinal tract and by inhibiting colonic bacterial overgrowth and metabolism of pathogens [22] [23] [24] . A recent systematic review and metaanalysis concluded that probiotics were effective treatments for IBS, showing that the relative risk (RR) of IBS symptoms persisting with probiotics compared with placebo was 0.79 (95% CI 0.70-0.89) [25] .
A recent consensus report stated with a 97% level of agreement, that to date there is insufficient evidence that probiotics are effective in reducing symptoms of diverticular disease [26] . Previous reviews on the use of probiotics in DD suggested that probiotics seem to be potentially useful in the management of this condition [20, 27] . In the last years, some new literature data on the role of probiotics in the management of diverticular disease have emerged. Based on this background, this study aimed to systematically review the efficacy of probiotic treatment in diverticular disease in terms of remission of abdominal symptoms and prevention of acute diverticulitis.
METHODS

Study selection
The search was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and MetaAnalyses) guidelines [28] . The electronic databases PubMed MEDLINE (U.S. National Library of Medicine, Bethesda, MD), EMBASE Elsevier, and Cochrane Central Register of Controlled Trials were systematically searched according to the following search strategy:
To assess all articles on colonic diverticulosis and diverticular disease of the colon: Explore colonic disease with an additional search using the key words: [(diverticulosis OR diverticular OR diverticula OR diverticulitis) AND (colon OR colonic OR sigmoid)] OR "diverticulosis, colonic" (MeSH). Clinical studies published up to December 2015 were considered for inclusion if they described in adults (>18 years) with DD the efficacy of probiotic treatment with respect to baseline (i) on improvement or remission of abdominal symptoms, and/or (ii) on prevention of acute diverticulitis.
Potentially relevant articles were screened for eligibility independently in an un-blinded standardized manner by the two reviewers (E.L., B.A.), initially by abstract and then by full text when necessary to determine whether they met the inclusion criteria. In detail, reviews, letters and/or editorials were excluded on the basis of the abstract and/or title; in other cases the judgement of inclusion/exclusion was based on the evaluation of the full-text. Disagreement between reviewers was resolved by discussion. The reference lists of the identified articles as well as of identified relevant reviews were manually searched for additional studies that may have been overlooked using computer-assisted search strategy.
Data extraction
We developed a data extraction sheet, pilot-tested it on three randomly-selected included studies, and refined it accordingly. One review author (E.L.) extracted the data from included studies and the second author (B.A.) checked the extracted data. Disagreements were resolved by discussion between the two review authors. The following information was extracted from each included paper: 1) author and year of publication; 2) characteristics of probiotic strains (single/multiple, type); 3) characteristics of study participants (number, mean age and gender); 4) type of diverticular disease; 5) study type and treatment arms; 6) type of intervention; 7) follow-up; 8) outcome data (remission of abdominal symptoms; occurrence of acute diverticulitis) / efficacy of intervention; 9) adverse effects of probiotics arms; 11) single or multiple centre.
Statistical analysis
Originally, a meta-analysis was planned in order to provide a numerical estimate of the overall effect of interest taking into consideration as outcome measure (effect size) the proportion of patients who showed a positive response to probiotics treatment with respect to baseline or with respect to controls defined as the complete regression or the absence of recurrence of abdominal symptoms. Due the heterogeneity of the retrieved studies, meta-analysis was not considered applicable. The efficacy of the interventions reported in the retrieved studies was described in a qualitative manner.
Quality assessment
The two reviewers evaluated the quality of all included studies using the Jadad scale for randomized controlled trials [29] . This scale awards a maximum of five points to each study. The considered categories are randomization, blinding of outcome J Gastrointestin Liver Dis, March 2016 Vol. 25 No 1: 79-86 assessment, description of withdrawals and dropouts, description and appropriateness of randomization and blinding. A study can be awarded a maximum of one point for each category. Discrepancy in quality assessment was discussed and resolved by two reviewers.
RESULTS
Search results
The electronic search strategy identified a total of 192 records from electronic databases, 171 of which were unique ( Fig. 1 ). These articles were screened on the basis of title and abstract and, after application of the inclusion and exclusion criteria, 13 articles were retrieved for full-paper evaluation. Of these 13 full-papers, 11 met the eligibility criteria and were subjected to data extraction [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . Two studies were excluded because in one the outcome (expression of TNF-alpha in segmental colitis associated with diverticulosis) [41] and in the other the intervention (oral polybacterial lysate suspension) was not pertinent to the present study purpose [42] . Manual searching of reference lists of potentially relevant papers and reviews did not add any more articles. Thus, 11 articles were included for qualitative synthesis.
Quality assessment
Details of the quality assessment of included studies are given in Supplementary Table S1 (see Supplementary material). Of the eleven included studies, four (36.4%) [30] [31] [32] 36 ] achieved 1 point, five (45.4%) [33-35, 37, 38 ] achieved 3 points, and two (18.2%) studies [39, 40] achieved 5 points according to Jadad scale.
Characteristics of included studies
The main characteristics of the 11 included studies are summarized in Table I . These studies were performed over a period of 20 years, from 1993 to 2013, and five of them were more recent than 2010 [36] [37] [38] [39] [40] . Six studies [30-32, 34, 35, 39] were single and five [33, [36] [37] [38] 40] were multicenter studies.
The 11 included studies investigated an overall total number of 764 patients with DD. Female gender was slightly prevalent (n=421, 55.1%). Patients had a mean age over 55 years in all studies, ranging from 58 to 75 years. In particular, five studies investigated patients with a mean age >65 years [30, 33, 35, 37, 38] .
Nine of the eleven studies were conducted in Europe, eight in Italy [30, 32-35, 3, 38, 40] and one in the Czech Republic [31] . From the remaining two studies, one was an Italian-Japanese collaboration [36] and one was performed in the USA [39] .
With regard to the type of DD, three studies included patients with symptomatic uncomplicated DD [31, 37, 38] and four studies patients with symptomatic uncomplicated DD in remission [33, 35, 36. 40] . The remaining four studies investigated patients with complicated or acute diverticulitis [30, 32, 34, 39] .
With regard to study type, two studies were double-blind randomized placebo-controlled trials [39, 40] , five studies were open randomized trials [33-35, 37, 38] , the remaining were non-randomized open studies [30] [31] [32] 36] .
Type of intervention, follow-up and outcome measure
With regard to the probiotics strains, in the majority of studies (72.7%), patients were treated with a single probiotic strain [30, 31, 33, 35, [37] [38] [39] [40] , and in only three studies multiple probiotic strains were employed [32, 34, 36] . Table II shows the strains of probiotics and their eventual prebiotic component used in the included studies. The most frequently investigated probiotic strains were different strains of Lactobacilli, while Bifidobacteria or other probiotic strains as Streptococcus or Escherichia were used less frequently. In three studies [36- 38] symbiotics were used, as probiotics were combined with prebiotics, and from one study [30] this information could not be extracted.
With regard to the follow-up protocol, the studies were very variable, and the follow-up periods ranged from 1 to 24 months. Two studies observed patients for less than 6 months [31, 32] , three studies followed patients for 6 months [36] [37] [38] , five studies followed patients for 12 months [30, 33, 34, 39, 40] and one study observed patients for 24 months [35] .
In addition, the interventions were variable between studies. In eight studies, the probiotic was administered together with a drug (antibiotic [rifaximin], anti-inflammatory agent as mesalamine or beclomethasone) [30-35, 39, 40] and compared with the efficacy of the drug alone. In five studies, however, there was a probiotic treatment arm without any associated drug [33, [36] [37] [38] 40] , in three of them the probiotic arm was a control arm [33, 35, 40] , in the remaining three studies, the probiotic was compared with a high-fibre diet [37, 38] or used together with phytoextracts [36] . With regard to the outcome measures, four studies evaluated the occurrence rate of acute diverticulitis [30, 33, 36, 40] , six studies assessed the reduction of abdominal symptoms [30, 31, 34, 37, 38, 39] and six studies assessed the remission of abdominal symptoms [31, 32, 33, 35, 36, 40] . Table III summarizes the type of interventions, follow-up protocols and outcome measures of the selected studies. Due to the poor quality of studies and the heterogeneity of study design, a meta-analysis could not be performed to provide a pooled estimate of the outcome measure. Details on the efficacy of probiotics treatment in the eleven included studies are reported in Table III . 
Adverse effects
Nine studies did not observe any adverse effects related to the probiotic treatment [30, 31, [33] [34] [35] [36] [37] [38] 40] . In one study adverse effects were not reported [32] and in one study [39] a relatively high proportion of adverse effects was present in all treatment arms (probiotic 39%, mesalamine 47% and placebo 41%).
DISCUSSION
This systematic review represents an attempt to provide an updated measure of evidence on the efficacy of probiotics in DD, in terms of symptoms control and prevention of acute diverticulitis. To our knowledge this is the first systematic review to collect all available data on the use of probiotics in DD. Previous reviews on probiotics in DD were performed some years ago (2009 and 2010), but they did not perform a systematical search of the literature, nor a meta-analysis and they included only four and seven studies, respectively. These suggested that probiotics seem to be potentially useful in the management of this condition [4, 27] .
This systematic review was conducted applying the rigorous methodology according to PRISMA guidelines [28] , the used search strategy was reported in full, and to enhance the yield of computer-based electronic database searching, the reference lists of relevant papers and reviews were manually searched. No date restriction was given and reports in English, German, French, Italian, and Spanish language were taken into consideration.
However, several limitations, largely arising from the nature of the included studies available for qualitative synthesis, impair the results of this systematic review. The overall number of retrieved studies was relatively low, the quality of included studies was relatively poor, as only two of the included studies were double-blinded randomized controlled trials, and study designs were heterogeneous making a meta-analysis not applicable. Moreover, five of the eleven included trials had been performed by the same authors. The follow-up periods in the single studies were very variable. The probiotic strains employed as treatment were very different as were the treatment protocols with regard to timing, dosage or combination with other drugs. Specific strains of probiotics may have different effects in patients with DD, and pooling different studies using different strains may not be a suitable method to evaluate their efficacy. The limited number of included studies was too low to analyze single probiotic strains. Also the type of DD was not homogeneous between studies as some studies investigated patients with uncomplicated DD and other studies patients with acute diverticulitis in remission. Some studies evaluated the maintenance of remission of abdominal symptoms, while other studies investigated the reduction of abdominal symptoms. All these variables may potentially influence the clinical response to probiotic treatment.
Data emerging from the qualitative synthesis of the retrieved studies clearly show that a meta-analysis on the efficacy of probiotics from these studies is not applicable to establish if probiotic treatment may be relevant in DD. However, with all the limits above described, the efficacy of probiotics in DD reported in the single controlled studies seem to show an apparent trend to a positive clinical response on abdominal symptoms or their recurrence, especially in patients with symptomatic uncomplicated DD [31] [32] [33] [34] [37] [38] [39] [40] (Table  III) . One possible explanation of this apparent clinical effect in the single studies lies in the fact that a significant proportion of patients with DD complain of symptoms resembling or overlapping those of IBS [6] [7] [8] . This further increases the difficulty to evaluate a possible efficacy of probiotic treatment on abdominal symptoms in patients with DD since probiotics have been shown to be effective treatment for IBS compared with placebo in a recent systematic review and meta-analysis [25] .
CONCLUSION
This systematic review showed that there remains still a paucity of evidence for the efficacy of probiotics in DD and high-quality data on efficacy of probiotics in DD are scant. Available data do not allow definite conclusions. Further investigation is required to understand how probiotics can be employed in this condition. 1) Was the study described as randomized?
2) Was the outcome assessment described as blinded?
3) Was there a description of withdrawals and dropouts?
4) Was the method of randomization well-described and appropriate?
5) Was the method of blinding of the assessment of outcomes well-described and appropriate? 6) Deduction of 1 point if methods for randomization or blinding were inappropriate. * see Reference 29) .
